RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference
Rhea-AI Summary
RxSight (NASDAQ: RXST) will present at the 25th Annual Needham Virtual Healthcare Conference. Management will participate in a fireside chat on April 16, 2026 at 8:00 a.m. PT. A live and archived webcast will be available on the company investor relations website.
Positive
- None.
Negative
- None.
News Market Reaction – RXST
In the Apr 6 session, RXST gained 5.72%, reflecting a notable positive market reaction. Our momentum scanner triggered 5 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 25 | Full-year results | Negative | -10.1% | 2025 revenue decline and wider net loss with 2026 guidance outlined. |
| Feb 11 | Earnings date notice | Neutral | -2.9% | Announcement of upcoming Q4 and 2025 results call date and time. |
| Jan 11 | Preliminary results & CFO | Positive | +14.1% | Preliminary 2025 revenue above prior guidance and new CFO appointment. |
| Jan 02 | Conference presentation | Neutral | +0.8% | Notice of J.P. Morgan conference presentation without new financial data. |
| Dec 22 | CFO transition | Negative | -10.0% | Planned departure of long-serving CFO and transition to successor. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Shares have reacted strongly to financial updates and leadership changes, while conference participation headlines have produced modest or inconsistent moves.
Over the past few months, RxSight has focused on financial disclosures and leadership transitions. On Dec 22, 2025, a CFO transition announcement coincided with a -9.98% move. Preliminary 2025 results and a new CFO on Jan 11, 2026 saw a strong +14.14% reaction, but final 2025 results and 2026 guidance on Feb 25, 2026 were followed by a -10.1% decline as revenue fell 4%. A prior conference appearance notice on Jan 2, 2026 had only a mild 0.77% impact, suggesting event-participation news alone has been a limited catalyst.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ALISO VIEJO, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., today announced plans to participate in the upcoming 25th Annual Needham Virtual Healthcare Conference. Management is scheduled to participate in a fireside chat on Thursday, April 16, 2026, at 8:00 a.m. Pacific Time. A live and archived webcast of the presentation will be available on the company’s investor relations website at https://investors.rxsight.com/.
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+®, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.
Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com
